Table 1

Summary of most often used outcome measures except smoking and their results

OutcomeInstrumentStudy identifier (author, year, first page No; see table A on bmj.com for references)DesignSignificance level*
DepressionCentre for Epidemiological Studies depression scale (CES-D)Barrera 2002-McKay 2002RCTNS
Bass 1998-Casper 1995-Brennan 1995-McClendon 1998RCTNS
Brennan 1998-489RCTNot reported
Glasgow 2003-410RCTNS
Houston 2002-2062 (“pure” peer to peer intervention)Cohort studyP<0.05
Lieberman 2003-920 (“pure” peer to peer intervention)Before and after studyP<0.001
McKay 2001-1328RCTNS
Tate 2001-1172RCTNot reported
Tate 2003-1833RCTNot reported
Winzelberg 2003-1164RCTP<0.01
Beck depression inventoryQuick 1999-Thesis (“pure” peer to peer intervention)Before and after studyNS
Medical outcome surveyGustafson 1999-1RCTNS
Social supportModified 6 items from interpersonal support evaluation list (ISEL)Barrera 2002-McKay 2002RCTP<0.05
Instrumental and expressive social support (IESS) scaleBass 1998-Casper 1995-Brennan 1995-McClenndon 1998RCTNS
4 item social support scale adapted from multidimensional scale of perceived social support (MPSS)Celio 2000-650RCTNS
5 point scale developed by the authorsGustafson 1999-1RCTP<0.05
6 item social support scaleGustafson 2001-435RCTP<0.01
“Perceived support from friends and relatives”Hamman 2002-Thesis (“pure” peer to peer intervention)Before and after studyNS
“Number of peer contacts initiated by group members”Harvey-Berino 2002-103RCTNS
Perceived social support-friends scaleHazzard 2002-69Controlled clinical trialP<0.05
Medical outcomes study social support surveyHouston 2002-2062 (“pure” peer to peer intervention)Cohort studyNS
“Increased perception of support from peers”Johnson 2001-E24Before and after studyP<0.05
Perceived social support scaleLacoursiere 2003-ThesisControlled clinical trialNS
Online social support scaleZabinski 2001-129Before and after studyNot reported
Healthcare useFewer phone calls to doctorsAlemi 1996-32Controlled clinical trialP<0.05
More phone calls to providersGustafson 1999-1RCTP<0.05
Visits to emergency departmentsGustafson 1999-1RCTNS
Non-emergency visitsGustafson 1999-1RCTNS
Shorter duration of hospital visitsGustafson 1999-1RCTP<0.05
Fewer hospital admissions during interventionGustafson 1999-1RCTP<0.05
Doctor's VisitsLorig 2002-792RCTNS
Eating disorderEating disorder examination questionnaire (EDE-Q)Celio 2000-650RCTP<0.01
EDE-Q-weight/shape subscaleWinzelberg 1998-339RCTNS
Winzelberg 2000-346RCTNS
Zabinski 2001-401RCTNS
Zabinski 2001-129Before and afterP<0.05
Eating disorder inventory (EDI) drive for thinness subscaleCelio 2000-650RCTP<0.05
Winzelberg 1998-339RCTNS
Winzelberg 2000-346RCTP<0.05
Zabinski 2001-401RCTNS
Zabinski 2001-129Before and after studyP<0.05
EDI bulimia subscaleWinzelberg 1998-339RCTNS
Winzelberg 2000-246RCTNS
Zabinski 2001-401RCTNS
Zabinski 2001-129Before and after studyNS
Body mass index (BMI)Winzelberg 1998-339RCTNS
Zabinski 2001-401RCTNS
Zabinski 2001-129Before and after studyNS
Weight lossBody weightHarvey-Berino 2002-103RCTNS
Harvey-Berino 2002-1254RCTP<0.05§
Tate 2001-1172RCTP<0.05
Tate 2003-1833RCTP<0.05
Diabetes controlGlycosylated haemoglobinBarrera 2002-McKay 2002RCTNS
Glasgow 2003-410RCTNS
Hamman 2002-Thesis (“pure” peer to peer intervention)Before and after studyNS
lafusco 2000-1853 (“pure” peer to peer intervention)Before and after studyP<0.001

For a complete list of all outcome measures and their results see table C on bmj.com.

All P values refer to a within group comparison (before and after a peer to peer intervention or complex intervention with peer to peer component) or a between group comparison between an arm with peer to peer intervention or complex intervention and an arm without peer to peer intervention or complex intervention. A significant finding usually means significant differences in favour of a peer to peer intervention (or intervention with peer to peer component), unless otherwise indicated.

  • * NS=non-significant at P<0.05 level.

  • † Differences between groups for randomised controlled trials, controlled clinical trials, cohort studies.

  • ‡ Differences within groups (before and after, person to person intervention).

  • § Favouring face to face support over internet group.

  • ¶ When considering control group (peer to peer support) as before and after design.